What Is Selank? GABA Pathways, Mechanisms, and Study Findings

Last updated: May 2026

Selank is a synthetic heptapeptide derived from tuftsin. A on its own occurring tetrapeptide (Thr-Lys-Pro-Arg) with immune-controlling action. The full Selank chain is Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed at the Institute of Molecular Genetics in Moscow in the 1990s. It aimed to study peptide effects on stress-linked behavior. Neurotrophic factor output in animal models. Selank is classified as a nootropic research peptide. According to a review in Bulletin of lab Science. Medicine (2008), Selank showed consistent effects on GABA-A receptor control. BDNF output in rodent lab systems.

Next Level Pharm supplies research-grade Selank tested to at least 99 percent purity by HPLC. Mass spec on every batch. HPLC confirms how pure the compound is relative to any flaws in the batch. Mass spec confirms the molecule weight matches the seven-amino-acid chain. A Certificate of Test ships with every lot.

The sections below cover Selank’s derivation from tuftsin, its GABA-A pathway action, BDNF. NGF effects, stress-linked behavior data, and sourcing standards.

Key Takeaways

1. What it is: Selank is a synthetic heptapeptide (seven amino acids) derived from the natural immunopeptide tuftsin. Developed for brain peptide research.
2. GABA-A control: Published studies describe Selank as an agent of GABA-A receptor action. Affecting blocking signaling in rodent CNS models.
3. Neurotrophic factors: Research has linked Selank to increased output of BDNF (brain-derived neurotrophic factor). NGF (nerve growth factor) in CNS tissue models.
4. Research origin: Most published Selank data comes from Russian research centers. Western-indexed randomized trial data is limited as of 2024.
5. Sourcing standard: Research-grade Selank needs HPLC purity above 99 percent. Mass spec proof of the seven-amino-acid chain. A lot-exact Certificate of Test.

Here is a closer look at each research area, what published studies describe. What to check when sourcing.

What Is Selank and How Was It Derived from Tuftsin?

Selank was made by extending the natural tetrapeptide tuftsin (Thr-Lys-Pro-Arg) with a Pro-Gly-Pro tail. Tuftsin is a fragment of immunoglobulin G. Has been studied for immune-controlling effects in cell models. The Pro-Gly-Pro extension was added to improve metabolic strength of the peptide in living fluids.

The result is a seven-amino-acid synthetic peptide with a longer half-life than tuftsin alone. This strength improvement allowed experts to study the compound more easily in animal models. According to a study published in Bulletin of Experimental Biology. Medicine (1999), Selank was developed mainly to study CNS effects. It tuftsin showed in early studies. Could not be studied reliably due to rapid breakdown in living systems.

How Does Selank Modulate GABA-A Receptors?

GABA-A receptors are the main blocking receptors in the central nervous system. GABA (gamma-aminobutyric acid) is the primary blocking brain signal. When GABA binds GABA-A receptors, it opens chloride ion channels and reduces neuronal firing. Compounds that modulate GABA-A action affect blocking signaling across the brain.

Selank has been described as a positive agent of GABA-A receptor action in rodent CNS models. This means it improves the blocking effect of GABA without activating the receptor directly. According to a study in Eksperimental’naya i Klinicheskaya Farmakologiya (2001). Selank showed GABA-A modulating properties in animal brain tissue assays. It correlated with behavior changes in the same models. The pathway is distinct from direct GABA agonism and does not involve benzodiazepine binding sites.

Browse brain peptides at Next Level Pharm for COA-tested Selank and linked brain peptide research compounds.

What Does BDNF and NGF Research Show for Selank?

BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) are neurotrophins. They support the survival, growth, and maintenance of neurons in the central and outer nervous system. Low BDNF is linked to several brain-related terms in published research. NGF is mainly key for outer and cholinergic neuron maintenance.

According to a study in Neuropeptides (2009). Selank use in rodent models was linked to increased BDNF. NGF mRNA output in hippocampal and cortical tissues. These changes were described as level-dependent in the studies. The process-level pathway for this effect is not fully defined. experts have proposed. Selank’s GABA-A control may indirectly affect neurotrophin gene action by changing downstream signaling patterns in the treated tissue.

What Does Anxiety-Related Behavioral Research Show?

Stress-linked behavior research is a key area for Selank in animal model research. Standard rodent behavior assays include the raised plus maze (EPM), open field test (OFT). Social link tests. These measure how animals respond to novel or threatening environments as proxies for stress states.

Published Selank research in Russian research describes reduced stress-like behavior in rodent EPM. OFT assays. According to a review in Psikhofarmalogiya i Biologicheskaya Narkologiya (2007). Selank showed consistent anxiolytic-like effects in many rodent behavior assays without sedation or motor impairment. This behavior profile differs from classical benzodiazepines, which show sedation at higher doses. The behavior data is lab. Western-indexed trial-based data for Selank is limited.

What Does Serotonin and Dopamine Research Show?

Beyond GABA and neurotrophins, Selank has been studied for effects on monoamine brain signal systems. Serotonin and dopamine are both studied in the context of mood control. Cognitive function in lab research. Several published studies examined whether Selank use changes monoamine turnover in rodent brain tissue.

Published findings describe Selank effects on serotonin metabolite levels in limbic brain regions. Dopaminergic changes were described in prefrontal cortex tissue in some studies. According to a review in Russian Drug action (2010), these monoamine effects were modest. Secondary to the primary GABA-A and neurotrophin pathway. Experts studying Selank should note, the monoamine data is less consistent across studies than the GABA-A and BDNF data.

How Is Research-Grade Selank Sourced?

Research-grade Selank needs HPLC purity at 99 percent or above. Mass spec proof of the seven-amino-acid chain. A lot-exact Certificate of Test. These records establish compound type and purity for each batch entering a study.

Selank is supplied as a lyophilized powder. Lyophilization removes moisture through freeze-drying under vacuum, which makes the peptide stable during room-temperature shipping. After receipt, refrigerated storage at 2 to 8 degrees Celsius is recommended. Products from unverified suppliers have shown purity shortfalls and chain discrepancies in independent reviews. Lot-level records is the minimum standard for reproducible brain peptide research.

Research area	Key published finding	Primary model
GABA-A modulation	Positive GABA-A modulation in CNS tissue	Rodent brain tissue assays
BDNF expression	Increased BDNF mRNA in hippocampus and cortex	Rodent CNS tissue
NGF expression	Increased NGF mRNA in treated tissue	Rodent CNS tissue
Behavioral (anxiety)	Reduced anxiety-like behavior in EPM and OFT	Rodent behavioral models
Monoamine effects	Serotonin metabolite changes in limbic regions	Rodent brain tissue

Frequently Asked Questions

What is Selank?

Selank is a synthetic seven-amino-acid peptide derived from tuftsin, a natural immunopeptide. It was developed at the Institute of Molecular Genetics in Moscow. It aimed to study A-A receptor control. Neurotrophin output in rodent CNS models. Selank is for lab research only. It is not approved for human use. Purity is tested to at least 99 percent by HPLC and mass spec on every batch.

How is Selank related to tuftsin?

Tuftsin is on its own occurring tetrapeptide (Thr-Lys-Pro-Arg) with immune-controlling action. Selank extends this chain with a Pro-Gly-Pro tail to improve metabolic strength in living fluids. The result is a seven-amino-acid compound that retains living action. Remains stable longer than tuftsin in lab systems. The Pro-Gly-Pro extension was added mainly to allow animal model studies. It was not feasible with tuftsin due to its rapid breakdown.

What is GABA-A modulation and why does it matter in research?

GABA-A receptors are the main blocking receptors in the CNS. They respond to GABA, the primary blocking brain signal, by opening chloride channels. Reducing neuronal firing. A compound that modulates GABA-A action affects how strongly blocking signals work across the brain. Selank has been described as a positive GABA-A agent in rodent tissue assays. This pathway is different from direct GABA agonism. Differs from benzodiazepine-type action at the same receptor.

What does BDNF mean and why is it studied with Selank?

BDNF stands for brain-derived neurotrophic factor. It is a protein that supports survival. Growth of neurons in the brain and spinal cord. Low BDNF output is studied as a marker in various brain-related terms in lab research. Selank has been linked to increased BDNF mRNA output in rodent hippocampal. Cortical tissue in published studies. This link is what connects Selank to brain-protection. Cognitive function research in animal model research.

What behavioral models are used in Selank research?

Selank research in animal models uses standard rodent behavior assays. The raised plus maze (EPM) measures stress-like behavior based on how often animals enter open versus enclosed arms. The open field test (OFT) measures locomotor action and exploratory behavior. Social link tests measure how animals interact in novel social contexts. These assays are proxy measures for stress-linked states. Published Selank data from these assays showed anxiolytic-like effects in treated rodent groups.

How does Selank differ from benzodiazepines in research?

Benzodiazepines are a class of compounds. It directly triggers GABA-A receptors at an exact binding site to produce sedation and calming. Selank modulates GABA-A receptor function without binding the classic benzodiazepine site. Published animal model data describes Selank’s anxiolytic-like behavior effects without sedation or motor impairment at the doses tested. This behavior profile is described in several Russian research publications. The process-level distinction between direct agonism and positive control is key for research grouping.

Is Western-indexed clinical data available for Selank?

Western-indexed randomized controlled trial data for Selank is limited as of 2024. Most published Selank research comes from Russian research centers. It is indexed in Russian drug action and biology journals. Some work appears in English-language journals. Comprehensive trial-based trial data matching Western study standards is sparse. Experts should consider the regional level of the evidence base when interpreting Selank findings. Lab animal model data is more extensive than trial-based data.

What purity is required for research-grade Selank?

Research-grade Selank is tested to at least 99 percent purity by HPLC. Mass spec confirms the molecule weight matches the seven-amino-acid Thr-Lys-Pro-Arg-Pro-Gly-Pro chain. A Certificate of Test for the exact lot records both results. These records establish type and purity tracking for each batch used in a study. Full lot records ships with every Selank order to all 50 states.

Summary

Selank is a synthetic seven-amino-acid peptide derived from tuftsin. It was developed to study GABA-A control, neurotrophin output. Stress-linked behavior in rodent CNS models.

Published research describes positive GABA-A control, increased BDNF. NGF mRNA output, and reduced stress-like behavior in animal assays. Most published work originates from Russian research centers. Western-indexed trial-based data is limited. Research-grade sourcing needs HPLC purity above 99 percent, mass spec proof of the chain. Lot-exact COA records.

What Should You Do Next?

If you are studying Selank for brain peptide research, here is how to approach sourcing:

• Match the research area to published model systems. GABA-A control studies use brain tissue assays. Behavior studies use rodent EPM or OFT protocols. BDNF studies use CNS tissue extraction.
• Review the Russian research carefully. Most published Selank data is concentrated in Russian pharmacology journals. Treat this evidence base as early.
• Browse research-grade Selank at Next Level Pharm for COA-tested options with full lot records.

People Also Read

• Semax Research Review: BDNF, Dopamine, and Neuroprotection Studies
• What Is KPV Peptide? Anti-Inflammatory Mechanisms and Study Findings

About the Author

Next Level Pharm Research Team

Alex M covers peer-reviewed findings in peptide science for Next Level Pharm, a US-based supplier of research-grade peptides verified to >=99% purity via HPLC and mass spectrometry on every batch.

 

Disclaimer: The information provided on this page is for educational and research purposes only. Next Level Pharm’s products are intended for laboratory research use only. They are not intended for human consumption, diagnostic, therapeutic, or medicinal purposes. This content does not constitute medical advice. Always consult a licensed healthcare professional before making any health-related decisions.